Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nurix Therapeutics

11.61
+0.17001.49%
Volume:541.48K
Turnover:6.22M
Market Cap:885.10M
PE:-4.14
High:11.72
Open:11.28
Low:11.09
Close:11.44
Loading ...

Innovative Capabilities and Promising Data Drive Buy Rating for Nurix Therapeutics

TIPRANKS
·
Yesterday

Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell

MT Newswires Live
·
17 Apr

BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479

Reuters
·
17 Apr

Nurix Therapeutics Inc - to Receive $5 Million Milestone Payment From Gilead

THOMSON REUTERS
·
17 Apr

Nurix Announces FDA Clearance of Ind Application for Gs-6791/Nx-0479 - a Novel Irak4 Degrader for Inflammatory Conditions

THOMSON REUTERS
·
17 Apr

Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions

GlobeNewswire
·
17 Apr

Stock Track | Nurix Therapeutics Plummets 7.50% as UBS Slashes Target Price

Stock Track
·
10 Apr

Stock Track | Nurix Therapeutics Plummets 7.50% as UBS Slashes Price Target

Stock Track
·
10 Apr

Nurix Therapeutics First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
10 Apr

Stock Track | Nurix Therapeutics Soars 5.08% Despite Price Target Cuts as Analysts Maintain Buy Ratings

Stock Track
·
10 Apr

Stock Track | Nurix Therapeutics Plummets 5.13% as Multiple Analysts Cut Price Targets Ahead of Earnings

Stock Track
·
09 Apr

Stock Track | Nurix Therapeutics Plummets 5.13% as Analysts Cut Price Targets Ahead of Earnings

Stock Track
·
09 Apr

Nurix Therapeutics price target lowered to $32 from $35 at Oppenheimer

TIPRANKS
·
09 Apr

Nurix Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
09 Apr

Nurix Therapeutics Inc : Needham Cuts Target Price to $27 From $28

THOMSON REUTERS
·
09 Apr

Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
09 Apr

Nurix Therapeutics Q1 Net Loss Narrows, Revenue Increases

MT Newswires Live
·
09 Apr

Nurix Therapeutics Inc reports results for the quarter ended February 28 - Earnings Summary

Reuters
·
09 Apr

Nurix Therapeutics Q1 EPS $(0.67) Beats $(0.78) Estimate, Sales $18.45M Beat $12.71M Estimate

Benzinga
·
09 Apr

Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire
·
09 Apr